Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Aggressive surgery for metastatic liver neuroendocrine tumors.

Norton JA, Warren RS, Kelly MG, Zuraek MB, Jensen RT.

Surgery. 2003 Dec;134(6):1057-63; discussion 1063-5.

PMID:
14668741
2.

Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.

Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT.

Arch Surg. 2003 Aug;138(8):859-66.

PMID:
12912744
3.

Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases.

Norton JA.

Best Pract Res Clin Gastroenterol. 2005 Aug;19(4):577-83. Review.

PMID:
16183528
4.

[Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors].

Kianmanesh R, O'toole D, Sauvanet A, Ruszniewski P, Belghiti J.

J Chir (Paris). 2005 May-Jun;142(3):132-49. Review. French.

PMID:
16142076
5.

Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors.

Yao KA, Talamonti MS, Nemcek A, Angelos P, Chrisman H, Skarda J, Benson AB, Rao S, Joehl RJ.

Surgery. 2001 Oct;130(4):677-82; discussion 682-5.

PMID:
11602899
6.
7.

Hepatic resection for metastatic neuroendocrine carcinomas.

Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK.

Am J Surg. 1995 Jan;169(1):36-42; discussion 42-3.

PMID:
7817996
8.

Resection of malignant primary liver tumors.

Holbrook RF, Koo K, Ryan JA.

Am J Surg. 1996 May;171(5):453-5.

PMID:
8651382
9.

Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.

Gillams A, Cassoni A, Conway G, Lees W.

Abdom Imaging. 2005 Jul-Aug;30(4):435-41.

PMID:
15759207
10.

Metastatic neuroendocrine hepatic tumors: resection improves survival.

Musunuru S, Chen H, Rajpal S, Stephani N, McDermott JC, Holen K, Rikkers LF, Weber SM.

Arch Surg. 2006 Oct;141(10):1000-4; discussion 1005.

PMID:
17043278
11.

Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver.

Elias D, Goéré D, Leroux G, Dromain C, Leboulleux S, de Baere T, Ducreux M, Baudin E.

Eur J Surg Oncol. 2009 Oct;35(10):1092-7. doi: 10.1016/j.ejso.2009.02.017. Epub 2009 May 21.

PMID:
19464140
12.

Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review.

Yedibela S, Gohl J, Graz V, Pfaffenberger MK, Merkel S, Hohenberger W, Meyer T.

Ann Surg Oncol. 2005 Oct;12(10):778-85. Epub 2005 Aug 18.

PMID:
16132374
13.

Highly aggressive policy of hepatic resections for neuroendocrine liver metastases.

Grazi GL, Cescon M, Pierangeli F, Ercolani G, Gardini A, Cavallari A, Mazziotti A.

Hepatogastroenterology. 2000 Mar-Apr;47(32):481-6.

PMID:
10791218
14.

Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver.

Pawlik TM, Vauthey JN, Abdalla EK, Pollock RE, Ellis LM, Curley SA.

Arch Surg. 2006 Jun;141(6):537-43; discussion 543-4.

PMID:
16785353
15.

[Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].

Fendrich V, Habbe N, Celik I, Langer P, Zielke A, Bartsch DK, Rothmund M.

Dtsch Med Wochenschr. 2007 Feb 2;132(5):195-200. German.

PMID:
17252361
16.

The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.

Chambers AJ, Pasieka JL, Dixon E, Rorstad O.

Surgery. 2008 Oct;144(4):645-51; discussion 651-3. doi: 10.1016/j.surg.2008.06.008.

PMID:
18847650
17.

Aggressive surgery for liver metastases from gastrointestinal stromal tumors.

Shima Y, Horimi T, Ishikawa T, Ichikawa J, Okabayashi T, Nishioka Y, Hamada M, Shibuya Y, Ishii T, Ito M.

J Hepatobiliary Pancreat Surg. 2003;10(1):77-80.

PMID:
12827476
18.

Surgery including liver resection for metastatic gastrointestinal stromal tumors or gastrointestinal leiomyosarcomas.

Nunobe S, Sano T, Shimada K, Sakamoto Y, Kosuge T.

Jpn J Clin Oncol. 2005 Jun;35(6):338-41. Epub 2005 May 31.

PMID:
15928191
19.

Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: a safe approach for radical resection.

Kianmanesh R, Sauvanet A, Hentic O, Couvelard A, Lévy P, Vilgrain V, Ruszniewski P, Belghiti J.

Ann Surg. 2008 Apr;247(4):659-65. doi: 10.1097/SLA.0b013e31816a7061.

PMID:
18362629
20.

Surgical therapy of liver metastases.

Kuvshinoff B, Fong Y.

Semin Oncol. 2007 Jun;34(3):177-85. Review.

PMID:
17560979

Supplemental Content

Support Center